HCAVII/IX-IN-1
HCAVII/IX-IN-1 (compound 4) is a hCAVII/IX inhibitor, with Ki values of 56.5 nM and 38.2 nM, respectively. hCAVII/IX-IN-1 can be used in anticancer research[1].
Product Specifications
CAS Number
[1300714-76-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Carbonic Anhydrase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Purity
99.84
Smiles
O=S(C1=CC=C(SC(N)=N2)C2=C1)(N)=O
Molecular Formula
C7H7N3O2S2
Molecular Weight
229.28
Precautions
H302, H315, H319, H335
References & Citations
[1]Abdoli M, et al. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides. J Enzyme Inhib Med Chem. 2017 Dec;32 (1) :1071-1078.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CA IX
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
363994 200 µL
LPCAT1 (Lysophosphatidylcholine Acyltransferase 1, AYTL2, PFAAP3, Acyltransferase Like 2, 1-alkylglycerophosphocholine O-acetyltransferase, Phosphonoformate immuno-associated protein 3, Acetyl-CoA, yso-PAF acetyltransferase)
Ask
View Details